Zisková marže společnosti Beam Therapeutics
Jaká je hodnota metriky Zisková marže společnosti Beam Therapeutics?
Hodnota metriky Zisková marže společnosti Beam Therapeutics Inc. je -35.09%
Jaká je definice metriky Zisková marže?
Zisková marže (Profit margin) je procento čistého zisku z celkových tržeb.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Zisková marže společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Beam Therapeutics
Čemu se věnuje společnost Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou zisková marže podobnou společnosti Beam Therapeutics
- Hodnota metriky Zisková marže společnosti Raunaq EPC International je -35.31%
- Hodnota metriky Zisková marže společnosti Hempstract je -35.31%
- Hodnota metriky Zisková marže společnosti Mobecom je -35.25%
- Hodnota metriky Zisková marže společnosti China Merchants Commercial Real Estate Investment Trust je -35.23%
- Hodnota metriky Zisková marže společnosti Cambium Networks Corp je -35.16%
- Hodnota metriky Zisková marže společnosti E-Land Apparel je -35.10%
- Hodnota metriky Zisková marže společnosti Beam Therapeutics je -35.09%
- Hodnota metriky Zisková marže společnosti Suncity je -35.09%
- Hodnota metriky Zisková marže společnosti The Motor & General Finance je -35.06%
- Hodnota metriky Zisková marže společnosti Inox Leisure je -35.01%
- Hodnota metriky Zisková marže společnosti PopReach je -34.99%
- Hodnota metriky Zisková marže společnosti Brooks Laboratories je -34.98%
- Hodnota metriky Zisková marže společnosti Paramount Inc je -34.97%